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ABSTRACT Peptides, corresponding to sequences in the N-terminal region of the skeletal muscle dihydropyridine receptor
(DHPR) II-III loop, have been tested on sarcoplasmic reticulum (SR) Ca2 release and ryanodine receptor (RyR) activity. The
peptides were: A1, Thr671-Leu690; A2, Thr671-Leu690 with Ser687 Ala substitution; NB, Gly689-Lys708 and A1S, scrambled A1
sequence. The relative rates of peptide-induced Ca2 release from normal (FKBP12) SR were A2  A1  A1S  NB.
Removal of FKBP12 reduced the rate of A1-induced Ca2 release by 30%. A1 and A2 (but not NB or A1S), in the
cytoplasmic (cis) solution, either activated or inhibited single FKBP12 RyRs. Maximum activation was seen at 40 mV, with
10 M A1 or 50 nM A2. The greatest A1-induced increase in mean current (sixfold) was seen with 100 nM cis Ca2. Inhibition
by A1 was greatest at 40 mV (or when permeant ions flowed from cytoplasm to SR lumen) with 100 M cis Ca2, where
channel activity was almost fully inhibited. A1 did not activate FKBP12-stripped RyRs, although peptide-induced inhibition
remained. The results show that peptide A activation of RyRs does not require DHPR Ser687, but required FKBP12 binding
to RyRs. Peptide A must interact with different sites to activate or inhibit RyRs, because current direction-, voltage-, cis
[Ca2]-, and FKBP12-dependence of activation and inhibition differ.
INTRODUCTION
The ryanodine receptor (RyR) calcium channel mediates
Ca2 release from internal stores in many cell types and is
an essential component of excitation-contraction coupling
(ECC) in striated muscle. In skeletal muscle, the L-type
Ca2 channel (dihydropyridine receptor, DHPR) is the volt-
age sensor for ECC, i.e., it senses T-tubule depolarization
and transmits a signal to the RyR, via a protein-protein
interaction which requires the loop between the second and
third repeats of the skeletal DHPR 1 subunit (II-III loop;
Tanabe et al., 1990). The II-III loop of the DHPR binds to
a 37-amino acid sequence, Arg1076-Asp1112, in the skeletal
muscle RyR (Leong and Maclennan, 1998).
The skeletal DHPR II-III loop increases [3H]ryanodine
binding to sarcoplasmic reticulum (SR) vesicles, and acti-
vates purified RyR channels in lipid bilayers (Lu et al.,
1994, 1995). Because ryanodine binds preferentially to open
RyR channels, the increase in [3H]ryanodine binding sug-
gests that native RyRs in SR vesicles are activated by the
II-III loop. The N-terminal part of the II-III loop (Glu666-
Glu726) also activates RyR channels, but fails to do so when
Ser687 is either phosphorylated or replaced by alanine (Lu et
al., 1995). A short peptide Thr671-Leu690 (peptide A) acti-
vates Ca2 release from SR, but peptides corresponding to
other segments of the loop do not (El-Hayek et al., 1995;
El-Hayek and Ikemoto, 1998). Since the actions of peptide
A on single RyR channels had not been reported, we ex-
amined its effects on RyRs. We also studied possible inter-
actions between the regulation of RyRs by peptide A and
their regulation by the FK506-binding protein (FKBP12), a
co-protein that coordinates RyR activity. FKBP12 is intrin-
sic to normal RyR function and may be involved in ECC
(Ahern et al., 1994, 1997a; Brillantes et al., 1994; Mayrle-
itner et al., 1994; Lamb and Stephenson, 1996). Four
FK506-binding proteins (FKBP12, Mr 12,000) are tightly
bound to each RyR monomer (Jayaraman et al., 1992;
Timerman et al., 1993; Wagenknecht et al., 1996, 1997).
The immunosuppressant drugs FK506 and rapamycin bind
to FKBP12 and dissociate it from the RyR (Timerman et al.,
1993, 1995). RyRs “stripped” of their FKBP12 co-proteins
display increased channel activity at low cytoplasmic Ca2
concentrations, with a loss of coordinated channel opening
to the maximum conductance (Ahern et al., 1997a).
In this study, the ability of peptide A1 (Thr671-Leu690)
and peptide A2 (with Ser687 replaced by Ala687) to release
Ca2 from native FKBP12 terminal cisternae (TC) vesi-
cles and from FKBP12-stripped vesicles was examined, as
well as the actions of the peptides on single native RyR
channels incorporated into lipid bilayers. The results
showed that peptide A1 released Ca2 from FKBP12 and
FKBP12-stripped TC vesicles, although release from the
RyRs lacking FKBP12 was markedly reduced. Ca2 release
by peptide A2 was greater than that by peptide A1. The
peptides had a dual action on RyR channel activity. Acti-
vation at40 mV was greatest with 100 nM cis Ca2, while
inhibition at 40 mV was strongest with 100 M cis Ca2.
Channel activation by the peptide was markedly reduced in
FKBP12-stripped RyRs. The inhibition of channel activity
was strongest when current flowed from the cytoplasmic to
the luminal side of the RyR and preferentially blocked
channel opening to maximum conductance levels. The re-
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sults show that these small DHPR II-III loop peptides can
both activate and inhibit single RyR channels and are likely




Rapamycin was obtained from Calbiochem and as a gift from Wyeth-
Ayerst (Princeton, NJ). Other chemicals and biochemicals were from
Sigma-Aldrich (Castle Hill, Australia). The DHPR II-III loop peptides
were synthesized using an Applied Biosystems 430A Peptide Synthesiser
with purification to 98 to 100% using HPLC and mass spectroscopy.
Peptide conformation was determined using NMR. Stock peptide solutions
(2 mM) were prepared in H20 and frozen in 20-l aliquots. Precise stock
solution concentrations were determined (Auspep Pty Ltd) using acid
hydrolysis followed by a standardized PTC (phenylthiocarbamyl) protocol
and analyzed by reverse phase HPLC. The following peptides were used in
this study.
Peptide A1
671Thr Ser Ala Gln Lys Ala Lys Ala Glu Glu Arg Lys Arg Arg Lys Met Ser
Arg Gly Leu690.
Peptide A2
671Thr Ser Ala Gln Lys Ala Lys Ala Glu Glu Arg Lys Arg Arg Lys Met Ala
Arg Gly Leu690.
Peptide NB
689Gly Leu Pro Asp Lys Thr Glu Glu Glu Lys Ser Val Met Ala Lys Lys
Leu Glu Gln Lys708.
Peptide A1S
Thr Arg Lys Ser Arg Leu Ala Arg Gly Gln Lys Ala Lys Ala Lys Ser Glu
Met Arg Glu.
Vesicle preparation
SR vesicles were isolated from the back and leg muscles of New Zealand
White rabbits using methods described by Saito et al. (1984) with minor
modifications (Ahern et al., 1994, 1997a). Native FKBP12 TC vesicles
were obtained from the 38%/45% sucrose interface after sucrose gradient
centrifugation. FKBP12 was “stripped” from TC vesicles by incubating the
vesicles with 20 M rapamycin for 20 min at 37°C, followed by centrif-
ugation at 540,000  g (and then resuspension) to remove rapamycin and
the FKBP12-rapamycin complex. The amount of FKBP12 remaining
bound to the TC vesicles was assessed by immunostaining Western blots of
the vesicles with anti-peptide antibodies raised against peptides corre-
sponding to the N-terminal sequence of FKBP12. The incubation proce-
dure with rapamycin removed all detectable FKBP12 from each of the 14
preparations used in the present experiments. “FKBP12-incubated” ves-
icles, incubated for 20 min at 37°C in the absence of rapamycin, retained
an amount of FKBP12 similar to that seen in native B4 vesicles. Details of
the FKBP12 “stripping” procedure, production of anti-peptide antibodies,
electrophoresis, and Western blotting are given in Ahern et al. (1997a).
Calcium release from TC vesicles
Extravesicular Ca2 was monitored at 710 nm with the Ca2 indicator,
antipyrylazo III, using a Cary 3 spectrophotometer. Identical release ex-
periments, performed at 790 nm, showed no changes in optical density
(OD) that would alter the rate of Ca2 uptake measured from recordings at
710 nm. A step increase in OD upon addition of ruthenium red was seen
in recordings at both 710 nm and 790 nm, and was subtracted from the
records shown in Figs. 1 and 2 (see Results). The temperature of the
cuvette solution was thermostatically controlled at 25°C and the solution
was stirred with a magnetic stirrer. Ca2 release was measured as described
by Timerman et al. (1993). TC vesicles (100 g protein) were added to the
cuvette, to a final volume of 2 ml, of a solution containing (in mM): 100,
KH2PO4 (pH  7); 4, MgCl2; 1, Na2ATP; 0.5, antipyrylazo III). Vesicles
were partially loaded with Ca2 by four sequential additions of CaCl2, each
initially increasing the extravesicular [Ca2] by 7.5 M (see Figs. 1 and
2). It was necessary to also suppress Ca2,Mg2-ATPase activity after
loading (using thapsigargin, 200 nm; Sagara and Inesi, 1991), to allow
extravesicular [Ca2] to increase after activation of the RyR. Peptide or
caffeine were the then added, followed by the RyR blocker ruthenium red
(to a final concentration of 5 M), to determine whether Ca2 release
through RyR channels was responsible for Ca2 release from SR. The
Ca2 ionophore A23187 (3 g/ml) was finally added to release the Ca2
remaining in the TC vesicles. A calibration curve was established at the
start of each experiment by measuring OD changes in response to four
sequential additions of 12.5 M CaCl2.
Lipid bilayers
Experiments were carried out at 20–25°C. The techniques are described in
Ahern et al. (1994) and Laver et al. (1995). Bilayers were formed from
phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine
(5:3:2 w/w) (Avanti Polar Lipids, Alabaster, AL) across an aperture with a
diameter of 200–250 m in the wall of a 1.0-ml Delrin cup (Cadillac
Plastics, Australia). In some experiments (e.g., Fig. 7) bilayers contained
only phosphatidylethanolamine and phosphatidylcholine (8:2 w/w). In
these experiments the negatively charged phosphatidylserine was left out to
remove possible effects on channel activity of bilayer surface potential
changes during changes in ionic composition.
TC vesicles (final concentration, 10 g/ml) and drugs were added to the
cis chamber. The bilayer potential was controlled, and single channel
activity recorded, using an Axopatch 200A amplifier (Axon Instruments,
Foster City, CA). For experimental purposes, the cis chamber was held at
ground and the voltage of the trans chamber controlled. Bilayer potential
is expressed in the conventional way as Vcis  Vtrans, (i.e., Vcytoplasm 
Vlumen).
Bilayer solutions
Bilayers were formed and vesicles incorporated into the bilayer using a cis
solution containing 250 mM CsCl (or 230 mM cesium methanesulfonate
(MS) plus 20 mM CsCl), 1 mM CaCl2, and 10 mM N-tris[hyroxymethyl]
methyl-2-aminoethanesulfonic acid (TES, pH 7.4 with CsOH) and a trans
solution containing 50 mM CsCl (or 30 mM CsMS plus 20 mM CsCl), 1
mM CaCl2, and 10 mM TES (pH 7.4). To prevent incorporation of multiple
channels into the bilayer, the cis solution was replaced by perfusion of the
cis chamber as soon as channel activity was observed. The cis perfusion
solution was identical to the initial cis solution, except that the [Ca2] was
varied (107 M or 104 M) as required. Ca2 was buffered to 107 M or
105 M using 1 mM BAPTA; 200 mM CsMS was added to the trans
chamber after channel incorporation to give symmetrical solutions.
In experiments examining RyR channel activity over a range of peptide
concentrations and at40 mV and40 mV, bilayer potential was changed
every 30 s over a 2-min period after each addition of drugs or peptides to
the cis chamber. Control activity was recorded for 2 min after addition of
200 mM CsMS to the trans chamber. Activity was then recorded for 2 min
after cis additions of 2 mM Na2ATP, 4 mM MgCl2, or 2 mM MgCl2 and
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then after each aliquot of peptide (three to eight different peptide concen-
trations were examined in each channel). Peptides were perfused out of the
cis chamber, and the channels were reexposed to Na2ATP plus MgCl2 and
then finally to ruthenium red (10–80 M). In some experiments 5 mM
Ca2 and 250 mM or 500 mM mannitol were added to the cis solution to
aid vesicle incorporation.
Recording and analysis of single channel activity
Currents were filtered at 1 kHz (10-pole low-pass Bessel, 3 dB) and
digitized at 5 kHz. Analysis of single channel records (using Channel 2,
developed by P. W. Gage and M. Smith) yielded channel open probability
(Po), frequency of events (Fo), open times, closed times, and mean open or
closed times (To or Tc) as well as mean current (I). The event discriminator
was set above the baseline noise at 20% of the maximum current, rather
than the usual 50%, so that openings to both subconductance and maximum
conductance levels were included in the analysis. Channel activity was
analyzed over two 30-s periods of continuous activity at 40 mV and two
30-s periods of continuous activity at 40 mV.
Values for the peptide concentration required for 50% activation (AC50)
and for 50% inhibition (IC50) of mean current (I) were obtained from
graphs of I as a function of peptide concentration, [P] (Figs. 5 and 6).
Some data were fitted with the equation
I 	Ic Imax/	1 AC50/
P/	1 	
P/IC50H
where Ic is the control I, Imax is the maximum current during activation,
and H is the Hill coefficient.
Statistics
Average data are given as mean SEM. The significance of the difference
between control and test values was tested 1) using a Student’s t-test, either
one- or two-sided and either for independent or paired data, as appropriate;
or 2) using the nonparametric “sign” test (Minium et al., 1993). Differences
were considered to be significant when p  0.05.
RESULTS
Peptide A1 releases Ca2 from terminal cisternae
The ability of peptide A1 to release Ca2 from native
FKBP12 TC vesicles was examined. As previously re-
ported (El-Hayek et al., 1995; El-Hayek and Ikemoto,
1998), A1 released Ca2 from TC. In the present experi-
ments, extravesicular [Ca2] increased when 200 nM thap-
sigargin was added to the cuvette after loading the SR with
Ca2 (Fig. 1, A and D).
The rate of Ca2 release with thapsigargan, just before
adding the peptide, was 55 nM/mg/min. Addition of pep-
tide NB did not alter the rate of Ca2 release, A1S induced
a small increase in Ca2 release, and A1 caused a larger
increase (Fig. 1, A–C). Ruthenium red (10 M) stopped
Ca2 release, if added while extravesicular [Ca2] was
increasing (Fig. 1, A and D), suggesting that the Ca2
release after addition of thapsigargin (Fig. 1 D), and acti-
vated by peptides A1 and A1S (Fig. 1 A), was through RyR
channels. The rate of Ca2 release induced by peptide A1
(maximum rate after A1 addition minus the rate in the
presence of thapsigargin) of 8 nmol/mg/min with 36 M
A1 (n  8) was significantly greater (p  0.007) than the
56  10 nmol/mg/min with 36 M A1S (n  6, Fig. 1 E).
Activation by A1S suggests that peptides containing pos-
itively charged residues in any sequence can induce Ca2
release from SR, via activation of RyRs. This observation is
consistent with the ability of polylysine to release Ca2
from SR (El-Hayek and Ikemoto, 1998).
Ser687 is not essential for peptide activation of
Ca2 release from SR
Surprisingly, and in contrast to results obtained with the
full-length II-III loop peptide (Lu et al., 1995), the Ser687
FIGURE 1 Peptides A1S, A1, and A2 release Ca2 from partially loaded
native FKBP12 TC vesicles. (A)–(D) Records of OD changes at 710 nm,
with changes in extravesicular [Ca2], measured using antipyrylazoIII (500
M) as the Ca2 indicator. In each record, extravesicular [Ca2] increased
when TC vesicles were added to the cuvette () and then declined as Ca2
was sequestered by the TC vesicles. The next four positive deflections ()
indicate addition of each aliquot of CaCl2 (7.5 M, final concentration).
The first arrow (t) indicates addition of 200 nM thapsigargin to block the
SR Ca2 ATPase. The second arrow (P) indicates addition of (A) 19 M
NB; (B) 36 M A1S; (C) 36 M A1; (D) 29 M A2. Ruthenium red (10
M) was added at the third arrow (r), before the ionophore A23187 (last
arrow, i, 3 g/ml). The vertical calibration is in M Ca2 (addition of 10
M extravesicular Ca2, increased OD by 0.2 units). (E) Maximum rate of
Ca2 release (nM/mg of TC vesicles/min) induced by peptides A1 (n  8,
filled circles) or A1S (n  6; filled squares). (F) Maximum rate of Ca2
release (nM/mg/min) induced by peptide A2 (n  11; filled circles) or NB
(n  3; filled squares) as a function of peptide concentration. The rates
shown are the maximum rate of release with peptide minus the preceding
rate with thapsigargin. Data points are averages  SE, using TC vesicles
from three different SR preparations.
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Ala substitution increased the ability of peptide A to acti-
vate Ca2 release from native FKBP12 TC vesicles. Ca2
release induced by A2 was significantly (p  0.05) greater
than that induced by peptide A1 and increased to 191  38
nM/mg/min (n  11) with 29 M peptide (filled circles,
Fig. 1 F). As with A1, the A2-induced Ca2 release from
SR was substantially reduced by 10 M ruthenium red (Fig.
1 D) and was thus through RyR channels.
Ca2 release with A1 is less after
FKBP12 removal
The experiments were repeated with FKBP12-incubated
and with FKBP12-stripped TC vesicles. FKBP12-stripped
vesicles required longer loading times than native or
FKBP-incubated vesicles (12 of 12 preparations) as ex-
pected from the greater RyR activity after FKBP12 removal
(Ahern et al., 1994, 1997a; Table 4). Since the rate of
depletion of extravesicular Ca2 is equal to the rate of Ca2
uptake minus the rate of Ca2 release, load time increases if
release increases. The time allowed for loading was in-
creased to 4 min between each addition of CaCl2 for both
FKBP12-incubated and FKBP12-stripped TC (prepared
in parallel from the same native TC preparation). Data were
obtained from vesicles from at least three different prepa-
rations. The amount of Ca2 loaded, determined from the
difference between the OD after the last load step and the
OD 4 min after A23187 addition, was 94.0 0.3% (n 25)
of the Ca2 added to the extravesicular solution for
FKBP12-incubated and 93.1  0.7% (n  22) in
FKBP12-stripped vesicles. Peptide A1 (36 M) was signif-
icantly less effective at releasing Ca2 from FKBP12-
stripped TC (Fig. 2 B) than from the FKBP12-incubated
TC (Fig. 2 A) at all peptide concentrations (Fig. 2 C).
The reduced Ca2 release from FKBP12-stripped vesi-
cles might have been due to factors other than the absence
of FKBP12. For example, the number of vesicles containing
active RyR channels might have been reduced after
FKBP12 removal. To test this possibility, the amount of
Ca2 that could be released through RyR channels (“releas-
able Ca2”) was measured by adding 5 mM caffeine after
thapsigargin, and expressing the increase in extravesicular
[Ca2] after 6 min as a fraction of the Ca2 loaded. Re-
leasable Ca2 was 64  10 5% in FKBP12-incubated TC
and 54  4% in the FKBP12-stripped TC (each number is
the average from two different preparations). The effect of
FKBP12 removal on the ability of the TC to release Ca2 in
general was examined by looking at the release in response
to 0.5 mM caffeine (a submaximal concentration). The
maximum rate of Ca2 release in response to caffeine was
expressed as a fraction of the releasable Ca2. The rates
were 13  3%/min (n  2) for FKBP12-incubated TC
and 12  1%/min (n  2) for FKBP12-stripped TC. Thus
the rates of release in response to caffeine were not influ-
enced by FKBP12 removal.
Rates of A1-activated Ca2 release were adjusted for
differences in the amounts of releasable Ca2 between
FKBP12-incubated and FKBP12-stripped TC (Fig. 2 D).
The A1-activated Ca2 release from the FKBP12-stripped
RyRs remained significantly less than that from FKBP12-
incubated RyRs at all peptide concentrations. The smaller
peptide-induced Ca2 release from the FKBP12-stripped
vesicles suggests that FKBP12 facilitates the activation of
RyRs by the II-III loop peptides.
Addition of peptide NB to one pair of stripped and
FKBP12-incubated vesicle preparations did not evoke
Ca2 release (Fig. 2 C, inset); the apparent negative release
is due to the fact that the release in the presence of thapsi-
gargin became slower with time, so that subtraction of the
FIGURE 2 Peptide A1-induced Ca2 release from partially loaded
FKBP12-stripped TC vesicles was less than that from FKBP12-incu-
bated TC. (A) and (B) show records of OD changes at 710 nm, with
changes in extravesicular [Ca2], using antipyrylazoIII (500 M) as a
Ca2 indicator. The Ca2 loading procedure is the same as in Fig. 1. The
first arrow (t) in each record indicates the addition of 200 nM thapsigargin.
The second arrow (P) indicates addition of 36 M of peptide A1 to (A)
FKBP12-incubated vesicles and (B) FKBP12-stripped vesicles. Ruthe-
nium red (third arrow, r, 10 M) was added before the ionophore A23187
(last arrow, i, 3 g/ml). The vertical calibration is in M of Ca2 (adding
10 M extravesicular Ca2 increased OD by 0.2 units). (C) Histograms of
the initial rate of Ca2 release (nM/mg/min of TC vesicle) in the presence
of peptide A1 (6–36 M), from FKBP12-incubated (n  6; double
cross-hatched bars) or FKBP12-stripped (n  6; cross-hatched bars).
Rates are the maximum rate with peptide minus the preceding rate with
thapsigargin. (C, inset) Rate of Ca2 release after adding peptide NB minus
the preceding rate with thapsigargin (n  2). (D) Initial rate of release as
fraction of the releasable Ca2, rather than [Ca2] per se (see text descrip-
tion). Data points are averages SEM using TC vesicles from three
different SR preparations.
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latter part of the record from the initial part gave a negative
rate.
Effects of peptide A1 on single RyR channels at
different cytoplasmic [Ca2]
Single RyR activity
Peptide A1 (6.5 nM to 32.5 M) was added to the cis
chamber, with 250/250 mM Cs (cis/trans), a [Ca2] of
107M, 105M, or 104M (cis) and 103 M (trans), 2 mM
cis Na2ATP, and 2 or 4 mM MgCl2, with bilayer potentials
of 40 mV or 40 mV. A1 had excitatory and inhibitory
effects on FKBP12 native channels (Fig. 3).
RyR activity at 40 mV with 100 nM or 100 M cis
Ca2 increased with 650 nM to 32.5 M cis A1, with no
change in the maximum open channel conductance (Fig. 3,
A and B). Inhibition by 6.5 M A1 (Fig. 3 A) was apparent
at 40 mV, with fewer openings to the maximum conduc-
tance. There were substantially fewer openings at 40 mV
during strong inhibition by 32.5 M A1 and long openings
(1 s) to low submaximal conductance levels (Fig. 3 B).
Channels recovered from the inhibitory effects of the pep-
tide within 15 s after perfusion of the cis chamber with
peptide-free cis solution. Channel activity remained higher
than control, especially at 40 mV, for 3–7 min after
washout. Activity declined at longer times after washout.
Thus inhibition by peptide A1 is rapidly reversible, while
activation is less reversible.
Effect of peptide A on the mean current
through RyRs
A1 increased mean current through native FKBP12 RyR
channels at 40 mV in 17 of 17 bilayers (100 nM, 10 M,
and 100 M cis Ca2). The greatest average peptide A1-
induced increase (6-fold) in mean current (I) through
RyRs occurred at 40 mV with 100 nM cis Ca2 (Fig. 4 A
and Table 1).
Average normalized I at 40 mV increased with A1
between 6.5 nM and 32.5 M, reaching a maximum with
6.5 M peptide with half-maximum concentration be-
tween 65 and 650 nM at each cis [Ca2]. I at 40 mV also
increased with [A1] at 100 nM and 10 M cis Ca2 (Fig. 4,
A and B), but fell below control with A1 6.5 nM when cis
[Ca2] was 100 M, where inhibition depressed I below
control values with a half-maximum [A1] of 0.65 M. It
is likely that the decline in activation at higher peptide
concentrations under the other conditions can be attributed
to inhibition.
Activation by A1 overcame Mg2 inhibition of RyRs.
Data for 100 nM and 100 M cis Ca2 were obtained in the
presence of 2 mM Na2ATP and 2 mM MgCl2, with a free
Mg2 of 0.6 mM, which inhibits RyRs by 50% (Laver et
al., 1997a, b). Data for 10 M cis Ca2 were obtained with
either 2 mM MgCl2 (n  5) or 4 mM MgCl2 (n  3, with
a free Mg2 of 2.1 mM, which inhibits skeletal RyRs by 
90%). Since 6.5 M A1 caused similar 2.9  0.9-fold
increase with 2 mM MgCl2 or 3.2  1.3-fold increase with
4 mM MgCl2, data for the two experiments were pooled for
Fig. 4. A1-induced activation was seen in 13 other bilayers
(data not shown) with 4 mM MgCl2, 2 mM Na2ATP, and
100 M cis Ca2.
Single channel characteristics of
A1-activated RyRs
During the strongest activation by 6.5 M A1 at 40 mV
with 100 nM cis Ca2, the open probability (Po) and open
frequency (Fo) were significantly greater than normal, and
mean closed time (Tc) was significantly reduced (Table 1).
Po and Fo at 40 mV were similarly increased by 6.5 M
peptide when cis [Ca2] was 100 M. In contrast, with
activating 10 M cis Ca2, mean open time (To) at40 mV
FIGURE 3 Biphasic action of peptide A1 on single native FKBP12
RyR channels. A1 at 6.5 M or 32.5 M increases the activity of recorded
at 40 mV, and reversibly depresses activity at 40 mV, with 100 nM cis
Ca2 (A) or 100 M cis Ca2 (B). The first records in each panel were
obtained under control conditions with 2 mM Na2ATP and 2 mM MgCl2
in the cis solution. The second and third sets of records show activity
recorded after 10 s exposure to 6.5 M or 32.5 M A1, respectively. The
final records were obtained4 min after removing peptide A1 from the cis
chamber by perfusion with 5 vol cis solution plus 2 mM Na2ATP and 2
mM MgCl2. The continuous line in each record shows the closed channel
current. The broken line shows the maximum open channel conductance.
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increased, while Fo was unaffected and indeed fell in two of
the five channels. Although the changes in parameter values
(I, Po, Fo, To, and Tc) for most individual channels at 40
mV were in the same direction as those at 40 mV, the
average changes were significant only with 10 M cis Ca2
(Table 1). Since inhibition by A1 was strongest at 40 mV
(Figs. 3 and 4 above), it presumably reduced the degree of
activation at this potential.
Removal of peptide A1 enhances RyR activity
Activity often increased further after A1 was perfused out of
the cis chamber. Average I and Po were significantly
greater than control (Table 1) after peptide removal, with all
cis [Ca2]s at 40 mV, while I, Po, Fo, and To were
significantly greater than control, and Tc significantly less,
at 40 mV with 100 nM or 10 M cis Ca2 (Table 1). As
in the presence of A1, the greatest relative increase in I
after perfusion was at 40 mV with 100 nM cis Ca2,
where I was double that before 32.5 M A1 washout and
13-fold greater than control. This result suggests that
peptide A is rapidly removed from the blocking site after
washout, but that it remains bound to the activation site.
Furthermore, the increase in channel activity with A1 re-
moval suggests that the degree of activation in the presence
of A1 was suppressed by the simultaneous inhibitory action
of the peptide. Data at 40 mV for the three cis [Ca2]s
were pooled to more clearly see the effects of activation or
inhibition by peptide A1 and peptide washout (Table 2).
There was a significant increase Fo with 6.5 M A1
(reflecting activation), while Fo fell with 32.5 M A1
(reflecting inhibition). Washout of 32.5 M A1 resulted in
significant increases in I, Po, Fo, and To, and a significant
decrease in Tc (reflecting recovery from inhibition). This
result remains consistent with the hypothesis that peptide A
is rapidly removed from its blocking site, but not from its
activation site, after washout.
Neither scrambled A1 (A1S) nor NB
activates RyRs
The strong activation and inhibition of RyR channels in-
duced by peptide A1 were not seen with A1S (Fig. 4 D).
Similarly, I was 0.79  0.24 under control conditions and
0.92  0.26 (n  6) after addition of 9.3 M of NB to the
cis side of RyRs at 40 mV with 100 M cis Ca2. Po, To,
Tc, and Fo were also unaffected by NB. Curiously, a small
inhibition of channel activity was seen with A1S. I (40
mV) was less than control in six of seven bilayers with 62
nM and 620 nM cis A1S, and in seven of seven bilayers
with 6.2 M cis A1S. A fall in I at 40 mV was also seen
in four of seven bilayers after adding 6.2 M A1S. The
average data in Table 3 show that 6.2 M A1S causes a
significant reduction in To at 40 mV as well as significant
reductions in Po, Fo, and To, or increase in Tc at 40 mV
(Table 3).
It is likely that interactions between the positively
charged residues in A1 and negative charges in the channel
pore cause the strong channel block by A1 (see Discussion
below). The clustered positive charges in the C-terminus of
A1 presumably provide a high positive charge density that
is effective in blocking the channel. The more diffuse
charges in A1S may interact less effectively with the same
negatively charged sites in the channel pore to give the
weak channel block seen in Fig. 4 and Table 3.
Peptide A2 activates and inhibits native
FKBP12 channels
The Ser687 Ala substitution did not alter the overall ability
of peptide A to activate or inhibit native FKBP12 RyRs.
However, A2 activated RyRs at considerably lower peptide
concentrations (AC50 between 3.6 and 7.25 nM, Fig. 5),
than those required for activation by A1 (AC50 of 65–650
nM, Fig. 4 above).
FIGURE 4 Average effects of peptides A1 and A1S on the relative mean
current flowing through native FKBP12 RyRs at 40 mV and 40 mV.
Relative mean current (Ip/Ic, where Ip is I in the presence of peptide and
Ic is I under control conditions) is plotted against the logarithm of
[peptide A] in nM. Symbols show average Ip/Ic and vertical bars show
SEM where this is greater than the dimensions of the symbol. Results for
A1 were obtained with (A) 100 nM cis Ca2, 2 mM Na2ATP, 2 mMMgCl2
(n  5); (B) 10 M cis Ca2, 2 mM Na2ATP, 2 mM MgCl2 (n  6) or 4
mM MgCl2 (n  3); (C) 100 M cis Ca
2, 2 mM Na2ATP, 2 mM MgCl2
(n  6). (D) Data for peptide A1S were obtained with 10 M cis Ca2, 2
mM Na2ATP, 2 mM MgCl2 (n  8).
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Although the affinity for A2 was higher than that for A1,
the degree of activation induced by the two peptides was
similar (2.5-fold with 10 M or 100 M cis Ca2). These
results are consistent with the ability of peptide A2 to
release Ca2 from native FKBP12 SR vesicles (above).
A2 also overcame inhibition of RyRs by 0.6 mM free Mg2
(with 2 mM MgCl2 in the 10 M cis Ca
2 solution, n  6),
or 2.1 mM free Mg2 (with 4 mMMgCl2 in the 100 M cis
Ca2 solution, n  12).
The affinity of the peptide for the inhibition site was also
increased by the Ser687 Ala substitution. The IC50 at 40
mV was 360 nM with 10 M and 100 M cis Ca2. The
cis [Ca2]-dependence of peptide A2-inhibition differed
from that with A1. A2 inhibited at40 mV with 10 M cis
Ca2 (dropping I to 28% of control, Fig. 5 A), and
weaker inhibition at 100 M cis Ca2, with I falling only
to control levels (Fig. 5 B).
Minimal peptide A-induced activation in
FKBP12-stripped RyRs
In contrast to strong activation of native FKBP12 chan-
nels by peptide A1 (Figs. 3 and 4), activity of FKBP12-
stripped RyRs at 40 mV was only slightly greater than
normal after exposure to 0.65 M or 32.5 M peptide A1
with 100 nM cis Ca2 (Fig. 6 A), and did not increase after
peptide addition with 10 M cis Ca2, at either 40 mV or
40 mV (Fig. 6 B).
The control activity of the FKBP12-stripped channels
(Fig. 6, A and B) was greater than that of native FKBP12
channels (e.g., Fig. 3 above) as expected (Ahern et al.,
1994). More than one channel was active in most bilayers
containing FKBP12-stripped RyRs (Fig. 6, A and B) and
long openings to low submaximal conductance levels were
apparent, particularly at 40 mV (Fig. 6 A). I (the mean
current through the bilayer divided by the number of chan-
nels in the bilayer) during control activity at each cis [Ca2]
was greater in FKBP12-stripped RyRs than in FKBP12
RyRs (Table 4).
An increase in activity at 40 mV was seen in 7 of 10
FKBP12-stripped RyRs with 65 nM to 32.5 M A1 with
100 nM cis Ca2, but was seen in only 3 of the 10 RyRs at
40 mV. On average, I at 40 mV (100 nM cis Ca2)
showed a significant 21% increase after addition of 65 nM
to 32.5 MA1 (Fig. 7 A), compared with the 600% increase
seen in native FKBP12 RyRs.
TABLE 1 Average single channel parameters for native FKBP12 RyRs at 40 or 40 mV exposed to peptide A1
40 mV 40 mV
I (pA) Po Fo (s
1) To (ms) Tc (ms) I (pA) Po Fo (s
1) To (ms) Tc (ms)
100 nM Ca2 (n  5)
Control 0.17  0.03 0.006 0.005 3  2 1.6 0.4 1317 429 0.22 0.04 0.001 0.001 1  1 1.1 0.2 1907 1046
6.5 M A1 1.04  0.03* 0.043 0.021# 22  9* 1.6  0.2 363  287* 0.48  0.14 0.018 0.011 7  5 1.7 0.3 396 116
Washout 2.11  0.17* 0.190 0.126# 40  10* 3.4  1.6 25  7# 0.74  0.17* 0.050 0.016* 23  8* 2.3 0.3* 65  24*
10 M Ca2 (n  6)
Control 1.92  0.74 0.289 0.138 47  19 3.6 1.7 350 283 0.30 0.06 0.018 0.006 16  5 1.3 0.3 120 53
6.5 M A1 3.56  0.71* 0.445 0.166# 84  18 5.9  2.6* 11  7 0.98  0.18* 0.097 0.030* 53  10* 1.7 0.4* 24  10*
Washout 4.97  1.32* 0.510 0.190* 78  16 8.6  4.9* 6  2 1.19  0.21* 0.131 0.041* 72  22* 1.8 0.1* 22  12*
100 M Ca2 (n  6)
Control 1.13  0.17 0.099 0.028 39  7 2.5 0.5 26 14 0.59 0.10 0.052 0.018 26  8 2.3 0.5 89  51
6.5 M A1 2.43  0.26* 0.282 0.051* 93  12* 2.8  0.2 8  2 0.45 0.22 0.071 0.067 22 17 1.7 0.5 574 243
Washout 2.82  0.39* 0.392 0.089* 106  24* 3.9  0.8 26  19 1.14 0.54 0.113 0.096 25 11 2.5 1.3 209 151
Data are shown as mean SE. The number of RyRs is shown in parentheses. Values are shown for control activity (with 2 mM Na2ATP and 2 mMMgCl2),
in the presence of 10 M A1, and after washout of A1 by perfusion with cis solution and addition of 2 mM Na2ATP and 2 mM MgCl2. Data in bold are
significantly different from the control data in the same experimental series.
*Significant according to Student’s t-test.
#Significant according to the “sign” test.
TABLE 2 Average single channel parameters at 40 mV for pooled data obtained with 100 nM, 10 M, and 100 M cis Ca2
n
40 mV
I (pA) Po Fo (s
1) To (ms) Tc (ms)
Control 17 0.40  0.06 0.023  0.007 14  4 1.5  0.3 669  372
6.5 M A1 17 1.04  0.03 0.062  0.025 53  10* 1.7  0.4 331  115
32.5 M A1 10 0.38  0.12 0.032  0.026 12  8# 1.3  0.3 1097  462
Washout 13 1.02  0.18* 0.100  0.038# 39  10* 2.2  0.5# 107  59*
Data are shown as mean  SE with the numbers of channels in parentheses. Data in bold are significantly different from the preceding condition, i.e., Fo
with 6.5 M A1 is greater than control, Fo with 32.5 M A1 is significantly less than with 6.5 M A1, and Fo after washout is significantly greater than
with 32.5 M A1.
*Significant according to Student’s t-test.
#Significant according to the “sign” test.
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Activity fell in all bilayers when 65 nM A1 was added
with 10 M cis Ca2 (n  7) or 100 M cis Ca2 (n  3)
and average normalized I was less than control at both40
mV and at 40 mV (Fig. 7, B and C). The fall in I at 40
mV and 40 mV was significant when 32.5 M A1 was
added with 10 M cis Ca2 and when [A1] was 0.65 M
with 100 M cis Ca2. In contrast to FKBP12-stripped
channels, FKBP12-incubated RyRs were strongly acti-
vated by A1 at 40 mV and 40 mV, with 100 nM cis
Ca2 (Fig. 7 D). Therefore, the loss of activation in
FKBP12-stripped channels was not due to the incubation
procedure. Inhibition without activation was seen in another
seven FKBP12-stripped RyRs when 65 nM to 32.5 M A1
was added with 100 M cis Ca2, 2 mM Na2ATP, and 4
mM MgCl2. The results confirm the Ca
2 release studies
and show that activation of native RyRs by peptide A1
depends on the presence of the FK506-binding protein.
Peptide A block of FKBP and
FKBP-stripped RyRs
Effects of ATP and Mg2
The block of RyRs by peptide A was unexpected because
6.5 M of the peptide caused significant ruthenium red-
sensitive Ca2 release from TC vesicles. The recording
conditions were varied to ascertain whether, in addition to
depending on cis [Ca2], channel block by peptide A was
influenced by cytoplasmic (cis) ATP or Mg2. Block was
seen with 100 M cis Ca2 in the absence of ATP or Mg2
(n  11) or with 2 mM ATP (without Mg2, n  6). Thus
channel block appeared to be independent of ATP or Mg2
in the cis solution.
Effect of permeant ions on the inhibition of RyRs by
peptide A1
Inhibition of RyR activity by peptide A was stronger at40
mV than at 40 mV (Figs. 3 and 4). This apparent mem-
brane potential-dependence might have been due to an
effect of membrane potential per se on peptide binding and
channel block, or it could be due to permeant cations
entering the pore from the opposite side of the channel (i.e.,
the trans bath). The latter possibility would suggest a block-
ing mechanism in which the peptide binds within the chan-
nel pore and is displaced by ion flow from the trans cham-
ber. To explore this possibility, we measured the effect of
varying the concentration of permeant ions in the trans
chamber (at constant membrane potential) on the inhibition
of native FKBP12 RyR channels by cis peptide. In these
experiments the bilayers were composed of only neutral
lipids (see Methods) to minimize bilayer surface potentials
and possible effects of the trans solution ionic strength on
surface potential and peptide binding. If charged lipids were
used, changes in the ionic composition of the trans bath
could alter peptide binding even if the binding site was not
in the pore. The trans concentration of the permeant cation,
Cs, but not the impermeant cation, choline, had a major
effect on the strength of peptide inhibition (Fig. 8).
TABLE 3 Average single channel parameters for seven native FKBP12 RyRs exposed to scrambled A1 (A1S) at 40 mV and
40 mV
40 mV 40 mV
I (pA) Po Fo (s
1) To (ms) Tc (ms) I (pA) Po Fo (s
1) To (ms) Tc (ms)
10 M Ca2
Control 1.77  0.69 0.293  0.146 56 19 3.8  0.2 87  61 0.60  0.12 0.044  0.010 40 12 1.3  0.3 34  10
6.2 M A1S 1.97 0.58 0.289  0.138 47 19 3.6  1.7# 345  283 0.53  0.07 0.018  0.006* 16 5* 1.3  0.4 121  53*
Values are shown for control activity (with 2 mM Na2ATP and 2 mM MgCl2) and in the presence of 6.2 M A1S. Data are shown as mean  1 SE and
values in bold are significantly different from the control data.
*Significant according to Student’s t-test.
#Significant according to the “sign” test.
FIGURE 5 Peptide A2 activates native FKBP12 RyRs at40 mV and
inhibits the RyRs at 40 mV. Relative mean current (Ip/Ic, where Ip is
I in the presence of peptide and Ic is I under control conditions) is plotted
against the logarithm of peptide A2 concentration (log[A2]) in nM. Sym-
bols show average Ip/Ic and vertical bars show 1 SEM where this is
greater than the dimensions of the symbol. Results for A2 were obtained
with (A) 10 M cis Ca2, with 2 mM Na2ATP and 2 mM MgCl2 (n  6);
(B) 100 M cis Ca2 with 2 mM Na2ATP and 4 mM MgCl2 (n  12).
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RyR activity at 0 mV was not altered by 4 M cis A1, but
was strongly inhibited by 8 M A1 (Fig. 8 A, trace 3).
Channel activity recovered when the bilayer was perfused
with solution lacking the peptide and the current direction
reversed when the Cs concentration in the trans chamber
was increased from 50 mM to 1000 mM (at 0 mV, Fig. 8
A, trace 4). The channel became relatively insensitive to A1
block and remained active with 32 M A1 (Fig. 8 A, trace
5). A similar reduction in peptide block after increasing
trans Cs to 1000 mM was seen in four of four experi-
ments. In contrast, in two experiments where 1000 mM
choline was added to the trans solution (to give a similar
increase in ionic strength to 1000 mM Cs), 8 M A1
blocked the RyR in the usual way (Fig. 8 B, trace 7). The
effect of the cation composition of the trans solution on the
half-inhibiting concentrations of A1 are summarized in Ta-
ble 5.
Increasing the concentration of the permeant cation (Cs)
in the trans solution from 50 mM to 1000 mM caused a
sixfold increase in the concentration of A1 required for 50%
block of the RyR. In contrast, there was a 40% reduction in
the [A1] required for half-maximum block in the presence
of 1000 mM choline (see also Fig. 8), possibly because the
trans Cs concentration was reduced to 30 mM.
Channel openings to submaximal conductances
are resistant to inhibition by peptides A1 and A2
FKBP12 channels
The reduced channel activity (and I) produced by adding
4 MA1 was due to fewer channel openings (Table 2), to
a reduction in the number of openings to the maximum
conductance in native FKBP12 (Fig. 3; Figs. 8 and 9), and
in FKBP12-incubated channels. The native FKBP12
RyR in Fig. 9 showed long openings (lasting for20 ms) to
the maximum conductance and to several submaximal con-
ductance levels under control conditions at 40 mV (Fig. 9
A). When 6.5 M peptide was added, there were only
occasional brief openings to the high conductance levels,
although long openings to submaximal conductance levels
remained and were longer than those in the control record
(Fig. 9 B). Channel openings to the maximum conductance
recovered when the peptide was perfused out of the cis
chamber (Fig. 9 C). The maximum conductance and three of
the submaximal levels (at 11, 33, and 67% of the maxi-
mum conductance) that could be seen under all conditions
are shown by the broken lines on the records and by the
arrows on the histograms. Similar effects of peptide block
on openings to the maximum conductance were seen at all
cis [Ca2] tested, and were seen to a lesser extent at
40 mV.
FKBP12-stripped channels
The effect of peptide A in preferentially blocking channel
openings to maximum conductance levels was also apparent
FIGURE 6 FKBP12-stripped RyRs are not significantly activated by
peptide A1. (A) Records from a bilayer with 100 nM cis Ca2. (B) records
from a second bilayer with 10 M cis Ca2. The cis solution also contained
2 mM Na2ATP and 2 mM MgCl2. The first records in each panel were
obtained under control conditions. The second and third records show
activity after 10 s exposure to 6.5 M or 32.5 M A1, respectively. The
final records were obtained 4 min after removing A1 by perfusion with
cis solution plus 2 mM Na2ATP and 2 mM MgCl2. Two RyR channels
were present in each bilayer. The continuous line shows the zero current
level. The broken lines indicate the maximum open conductance of one
(first line) or two (second line) channels.
TABLE 4 Average control mean current (I) through
FKBP12 (native or incubated) or FKBP12-stripped RyRs at
each of the three cis Ca2 concentrations listed
cis [Ca2]
100 nM 10 M 100 M
I (pA) I (pA) I (pA)
FKBP12 native
40 mV 0.17  0.03 1.77  0.69 1.13  0.17
40 mV 0.22  0.04 (6) 0.63  0.17 (7) 0.59  0.10 (6)
FKBP12-stripped
40 mV 1.23  0.36* 3.85  0.64* 4.02  1.28*
40 mV 1.53  0.30* (10) 2.54  0.58* (8) 2.14  0.84* (3)
FKBP12 incubated
40 mV 0.48  0.11*#
40 mV 0.46  0.06*# (4)
I is the mean current across the bilayer divided by the number of RyR
channels in the bilayer. Data are shown as mean  1 SE with the number
of bilayers given in parentheses.
*Significantly greater (Student’s t-test) than values obtained in native
FKBP12 RyRs at the same potential and cis [Ca2].
#FKBP12 incubated values are also significantly less than the equivalent
FKBP-stripped data.
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in FKBP12-stripped channels that demonstrated consider-
able submaximal conductance activity in the absence of
peptide. As previously reported for FKBP12-stripped chan-
nels (Ahern et al., 1994, 1997a), three major submaximal
conductance levels were apparent in the FKBP12-stripped
channels. In the channel shown in Fig. 9, D–F, these levels
were at 17, 33, and 67% of the maximum conductance.
Only very brief openings (1 ms) to the maximum conduc-
tance were seen under control conditions, although long
openings to the 67% level were apparent. Fewer, briefer
openings to the 67% level were observed with 6.5 M
peptide, although long openings to the 17 and 33% levels
remained (Fig. 9 E). Openings to the 67 and 100% levels
recovered when the peptide was perfused out of the cis
chamber (Fig. 8 F). Similar conductance levels and peptide-
induced block of openings to the maximum conductance
were seen in FKBP12-stripped channels at 40 mV, and
with 100 nM and 100 M cis Ca2.
Incidental observations: RyR activation by ATP and
inhibition by Mg2
Addition of 2 mM ATP induced the expected increase in
average I through native FKBP12 channels at both 40
mV and 40 mV with 100 M cis Ca2 (n  20, Fig. 10).
Addition of 4 mMMgCl2 (2.1 mM free Mg
2) then reduced
I at positive and negative potentials, but to levels that
FIGURE 7 Average effects of peptide A1 on the mean current flowing
through FKBP12-stripped RyRs and FKBP12 incubated RyRs at 40
mV and 40 mV. Relative mean current (Ip/Ic, where Ip is I in the
presence of peptide and Ic is I under control conditions) is plotted against
the logarithm of [peptide A1] in nM. Symbols show average Ip/Ic and
vertical bars show 1 SEM where this exceeds the dimensions of the
symbol. Results with FKBP12-stripped RyRs were obtained with 2 mM
Na2ATP and 2 mM MgCl2, and (A) 100 nM cis Ca
2 (n  10); (B) 10 M
cis Ca2 (n  8); (C) 100 M cis Ca2 (n  4). (D) Data for FKBP12
incubated RyRs were obtained with 100 nM cis Ca2, 2 mM Na2ATP, and
2 mM MgCl2 (n  3).
FIGURE 8 Inhibition of RyR activity at 0 mV by peptide A1 in the cis
solution is relieved by increasing the permeant ion concentration in the
trans solution. Bilayers contained 80% phosphatidylethanolamine and 20%
phosphatidylcholine. The cis solution contained (in mM): 230 CsMS, 20
CsCl, 0.1 CaCl2, 2 Na2ATP, and 2 MgCl2. (A, Traces 1–3) Channel activity
with 50 mM trans Cs (30 mM CsMS 20 mM CsCl) so that Cs flowed
from the cis to trans bath. Addition of 8 M A1 almost abolished RyR
activity. Traces 4 and 5 were from the same channel at 0 mV after
perfusion with A1-free solution and increasing trans [Cs] to 1000 mM by
trans addition of 4 M CsMS, so that Cs flow was trans to cis. Under these
conditions, 32 M A1 produced relatively little inhibition. (B) In separate
experiments, 1000 mM choline, (an RyR impermeant cation) was added
to the trans solution initially containing 50 mM Cs. Adding choline
diluted the trans [Cs] to 30 mM, reducing RyR conductance and current
amplitude. In contrast to 1000 mM trans Cs, the 1000 mM trans choline
did not reduce peptide A1 block of RyRs.
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remained higher than those before addition of ATP. The
response to both ATP and 4 mM MgCl2 was similar in the
20 normal and 16 FKBP12-stripped channels, although
channel activity fell to levels that were not significantly
different from control when 4 mM MgCl2 was added to the
FKBP12-stripped channels at40 mV (Fig. 10 B). If 2 mM
MgCl2 was added simultaneously with 2 mM Na2ATP (with
0.6 mM free Mg2), channel activity remained at levels that
were not significantly different from control or greater than
control (Table 6).
Since 2 mM ATP alone activated the channels (Fig. 10),
channel activity with 2 mM Na2ATP plus 2 mM MgCl2
must have been depressed from the ATP-activated level.
The reduction in activity with 0.6 mM free [Mg2] does not
appear to be significantly less than the block with 2.1 mM
Mg2, and the block with either Mg2 concentration is
considerably less in the presence of ATP than it is when
ATP is absent (Laver et al., 1997a), confirming previous
observations in cardiac RyRs (Xu et al., 1996). No consis-
tent differences were noted between 1) the native FKBP12
and FKBP12-stripped channels, or 2) between the effects of
ATP and Mg2 at different cis Ca2 concentrations.
DISCUSSION
We show here that peptide A (corresponding to the N
terminal of the DHPR II-III loop), at concentrations from 65
nM to 32.5 M, activates native RyR channels at 40 mV
with cis [Ca2]s of 100 nM, 10 M, and 100 M. The
peptide also inhibited channel activity in native RyRs and,
at4 M, reduced the mean current at40 mV to less than
control levels when cis [Ca2] was 100 M. Activation by
peptide A was expected because it has been shown that the
peptide increases [3H]ryanodine binding to, and releases
Ca2 from, SR vesicles (El-Hayek et al., 1995). The block-
ing action of the peptide was not expected from previous
single channel studies on longer segments of the II-III loop
(Lu et al., 1995), although a decline in the rate of peptide-
activated Ca2 release from SR is apparent with higher
concentrations of a fragment of the peptide (El-Hayek and
Ikemoto, 1998).
Peptide A activation of the skeletal RyR
Peptide A activation overcame Mg2 block of RyR activity.
Mg2 block reduced RyR activity and suppressed Ca2
release through the channel in resting muscle (Lamb and
Stephenson, 1991). Peptide A activated RyRs in the pres-
ence of 0.6 mM free Mg2 in Ca2 release experiments,
or 0.6 mM to 2.1 mM free Mg2 in single channel exper-
iments (with 107 to 104 M Ca2). Thus, peptide A-in-
duced activation mimics ECC insofar as it can overcome
Mg2-inhibition of RyR activity.
The degree of activation of the RyR by peptide A was not
as large as expected for the primary trigger of RyR opening
during ECC. Channel open probability (Po) with 0.65–6.5
M peptide remained well below 1.0 (Table 1), while the
rate of Ca2 release from TC in our experiments, and in the
faster release in stop-flow experiments (El-Hayek and Ike-
moto, 1998), remain slower than Ca2 release during ECC
(Melzer et al., 1987). The lower-than-expected activation
could indicate that a conformational change in the II-III
loop occurs during ECC, but does not occur when the
peptide is isolated from the remainder of the DHPR and is
not under the influence of the T-tubule membrane potential.
Alternatively (or in addition), the relatively small increase
in I and Po could be due to the strong concurrent inhibition.
Although inhibition per se was not apparent in SR Ca2
release, inhibition could have reduced the degree of activa-
tion (as indicated by the increased activity after removal of
peptide A from the cis chamber).
It is likely that peptide A activation of the RyR depends
on the highly positively charged residues in the C half of the
peptide. A smaller II-III loop peptide containing these ar-
ginine and lysine residues (Arg Lys Arg Arg Lys Met Ser
Arg Gly Leu), increases 3H-ryanodine binding and releases
Ca2 from SR (El-Hayek and Ikemoto, 1998; Dulhunty et
al., 1999). Thus it is likely that it is this segment of the II-III
loop that binds to skeletal RyRs at residues 1076–1112
(Leong and Maclennan, 1998). Skeletal type ECC also
requires region D3, residues 1872–1923 (Nakai et al.,
1998a), and perhaps region D2 (1342–1403, Yamazawa et
al., 1997) of the RyR. The involvement of these diverse
regions of the RyR indicates a complex transduction path-
way through the channel protein between its interaction
with the DHPR and the ion channel pore. This is not
surprising, given the size and complex structure of the
protein (Radermacher et al., 1994; Orlova et al., 1996;
Wagenknecht and Radermacher, 1997; Wagenknecht et al.,
1997).
Importance of Ser687 in II-III loop activation
of RyRs
In our studies, enhanced peptide-induced Ca2 release from
TC and activation of single RyRs at lower peptide concen-
trations were seen with the Ser687 Ala substitution. This is in
contrast to the abolition of activation seen with the same
substitution in the full II-III loop (Lu et al., 1995). However,
Ser687 Ala substitution in the entire DHPR 1 subunit does
not alter the ability of the DHPR to support skeletal-type
ECC (Nakai et al., 1998b). The reasons for these conflicting
TABLE 5 The effect of the permeant ion concentration in the
trans chamber on the ability of peptide A to block RyR




50 mM Cs 6 5.0  0.4 M
1000 mM Cs 4 24.0  5.0 M
30 mM Cs  1000 mM choline 2 2.8  0.2 M
Experimental conditions and protocols are described in the text and in the
legend to Fig. 8.
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results are not clear. However, the Ser687 Ala substitution
could well produce a structural change that prevents the full
II-III loop from activating the RyR, but that enhances acti-
vation by the shorter peptides. Enhanced activation may not
have been detected within the resolution of the ECC studies
(Nakai et al., 1998b).
The FK506 binding protein
The ability of peptide A to activate RyRs was substantially
reduced in FKBP12-stripped RyRs. The removal of
FKBP12 reduces the number of RyR openings to the max-
imum conductance, but does not alter the regulation of the
channel by Ca2 (Ahern et al., 1997b), ATP, Mg2, or
caffeine (see Results). The influence of FKBP12 on channel
activation by A1 is unique among these ligands, which
supports suggestions that FKBP12 plays a role in RyR
activation during ECC (Ahern et al., 1994, 1997a; Brillantes
et al., 1994; Mayrleitner et al., 1994; Lamb and Stephenson,
1996).
The putative FKBP12 binding domain at 2407–2520
(Cameron et al., 1997) is located on the surface of the RyR
that opposes the T-tubule membrane (Wagenknecht et al.,
1997). Four FKBP12 molecules bind to each RyR, i.e., one
per subunit (Jayaraman et al., 1992; Timerman et al., 1993;
Wagenknecht et al., 1996, 1997). The II-III loop binding
domain must be located on the same surface of the RyR to
enable the DHPR to bind to the RyR. Since skeletal muscle
DHPRs are clumped into tetrads, which oppose every sec-
ond RyR (Block et al., 1988), each subunit of every second
RyR is likely to interact with the II-III loop of one of the
DHPRs in a tetrad. The T-tubule opposing surface of each
subunit of the RyR must contain an FKBP12 binding site
and a II-III loop binding site. An interaction between
FKBP12 binding and activation of RyRs by the II-III loop
has been suggested by the fact that FK506 can disrupt
depolarization-induced Ca2 release from the SR (Lamb
and Stephenson, 1996).
Physiological interactions between the DHPR and
the RyR during ECC
It is not known whether the II-III loop is bound to the RyR
in vivo or binding occurs only during ECC. In the latter
case, binding alone could be sufficient to activate the RyR
although, as mentioned previously, the activation produced
by peptide binding is not as strong as might be expected.
However, there is evidence that a complex can be formed
between the RyR and DHPR (Marty et al., 1994; Murray
FIGURE 9 Effects of block by peptide A1 on conductance levels in single native FKBP12 (A–C) and FKBP12-stripped (D–F) channels at 40 mV,
in the presence of 10 M cis Ca2. The upper records (A and D) show control activity, the middle records (B and E) were obtained after adding 6.5 M
A1 to the cis solution, and the lower records (C and F) show recovery of high conductance activity after A1 perfusion out of the cis chamber. The continuous
lines show the zero current for each channel. All-points histograms, showing the probability of activity to current levels (in pA), are shown beside each
record. The arrows on the histograms point to current levels [identified by I in the records (broken lines) and as peaks or discontinuities in the histograms
(arrows)], that are common to all conditions. These are the maximum conductance and three submaximal conductance levels for the FKBP12 channel
and the FKBP12-stripped channel.
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and Ohlendieck, 1998). If there is a stable II-III loop-RyR
complex, then RyR activation during ECC could depend on
a conformational change in the II-III loop being transmitted,
through the DHPR/RyR interaction site, to the RyR.
Although studies with synthetic peptides and RyRs in
bilayers or vesicles clearly show that peptide A can activate
the calcium release channel, apparently conflicting results
have been obtained from ECC studies with dysgenic myo-
tubes expressing chimeric DHPRs. It is clear that the skel-
etal ECC (independent of external Ca2) requires the skel-
etal II-III loop and will not proceed if the loop contains the
cardiac sequence (Tanabe et al., 1990). However, when
chimeras are constructed with parts of the II-III loop, skel-
etal-type ECC proceeds when the A portion contains either
the cardiac or skeletal sequence (Nakai et al., 1998b). Skel-
etal ECC has an absolute requirement for the skeletal se-
quence in residues 725–742 (encompassed in the C portion
of the II-III loop according to El-Hayek et al., 1995). Lu et
al. (1994, 1995) found that both the cardiac and skeletal
II-III loops increased ryanodine binding to SR vesicles and
activated RyR channels, suggesting that both the cardiac
and skeletal II-III loops bind to the skeletal RyR, and in
agreement with the ECC studies. The II-III loops presum-
ably bind to the RyR at the A region, which contains several
arginine and lysine residues in both the skeletal and cardiac
isoforms.
TABLE 6 Average control mean current (I) through FKBP12 (native) or FKBP12-stripped RyRs at each of the three cis Ca2
concentrations listed
cis [Ca2]
100 nM 10 M 100 M
I (pA) I (pA) I (pA)
FKBP12 native
40 mV Control 0.34  0.04 (6) 0.75  0.04 (7) 0.45  0.08 (6)
ATP/Mg 0.22  0.04 0.63  0.17 0.59  0.10
40 mV Control 0.15 0.04 0.64  0.17 0.72  0.16
ATP/Mg 0.17  0.03 1.77  0.69 1.13  0.17
FKBP12-stripped
40 mV Control 1.19 0.17 (8) 1.87  0.46 (8) 2.03  0.56 (3)
ATP/Mg 1.37  0.25 2.53  0.58* 2.14  0.84
40 mV Control 1.68 0.55 2.86  0.73 2.65  0.52
ATP/Mg 1.41  0.40 3.85  0.64* 4.02  1.37
I is the mean current across the bilayer divided by the number of RyR channels in the bilayer. Data are shown as mean 1 SE with the number of bilayers
given in parentheses.
*Significantly greater (Student’s t-test) than control values.
FIGURE 10 Histograms compare the effects of Na2ATP and MgCl2 on the mean current through native FKBP12 and FKBP12-stripped channels.
Control channel activity was recorded in the presence of 104 M Ca2 (black bars). Activity after adding 2 mM ATP is shown in the gray bars and activity
with 2 mM Na2ATP plus 4 mM MgCl2 is shown in the cross-hatched bars. Data are given as mean  SE. The asterisks () indicate that the mean value
is significantly different from that for the preceding condition, p  0.01. The cross-hatch symbols (##) indicate that mean current with 2 mM Na2ATP plus
4 mM MgCl2 is significantly different from the that under control conditions, p  0.01.
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One hypothesis that could explain most observations is
that the positively charged A region of the II-III loop binds
to the RyR, causing an increase in RyR activity. Full acti-
vation of the RyR requires a conformational change at the
binding site, which is initiated by the voltage sensor in the
S4 segment of the DHPR and is transmitted through the C
region (725–742) of the II-III loop. Either the skeletal or
cardiac sequence of the II-III loop binds to (or interacts
with) the skeletal RyR. However, skeletal-type ECC re-
quires transmission of T-tubule depolarization to the II-III
loop/RyR interaction site, and this can only proceed if
residues 725–742 contain the skeletal DHPR sequence.
Peptide A inhibition of the skeletal RyR
The peptide inhibition site is distinct from the II-III loop
activation site because 1) inhibition is greatest at 100 M
cis Ca2, while activation is greatest at 100 nM cis Ca2; 2)
inhibition, but not activation, depends on the direction of
current flow; and 3) unlike activation, inhibition is not
disrupted by removing FKBP12. The fact that inhibition by
cis peptide A was reduced when Cs flows from trans to cis
is consistent with the peptides blocking by binding to the
pore or vestibule of the RyR, since Cs could enter the pore
from the trans bath and compete with the peptide for its
binding site. This hypothesis is supported by the fact that
high trans [choline], which does not pass through RyR
channels, did not affect cis peptide inhibition. The sensitiv-
ity of peptide block to the flow of permeant cations may
also account for its voltage-dependence, since at negative
potentials the electric field in the pore will favor cation
permeation from the trans side, whereas positive potentials
will oppose it.
In contrast to peptide A, the full-length DHPR II-III loop
has not been reported to inhibit RyR activity (Lu et al.,
1994, 1995). Failure of the full-length II-III loop to block
can be explained if the blocking site is in the channel pore,
since the bulk of the longer peptide could restrict its access
to the blocking site. The observation is consistent with the
hypothesis that there are separate inhibition and activation
sites.
Permeant ions flowing from the opposite side of a chan-
nel have been shown elsewhere to reduce the binding of
pore blocking peptides [e.g., charybdotoxin block of the
Ca2-activated K channel (MacKinnon and Miller,
1988)]. A toxin that blocks the K channel pore also blocks
RyRs, possibly because positively charged arginine and
lysine residues in the peptides bind to negative charges near
the channel pore (Mead et al., 1998). Peptide A, also rich in
arginine and lysine residues, may bind to the RyR at a site
similar to the toxin binding site.
Two factors that need to be considered in developing a
model for peptide binding in the channel pore are 1) inhi-
bition depends on cis [Ca2] and is greatest at 100 M cis
Ca2; and 2) inhibition preferentially targeted maximal
conductance openings, while leaving openings to submaxi-
mal conductances intact. The blocking mechanism must
differ from ryanodine block, which causes equal depression
of all conductance levels (Ahern et al., 1997a). The sensi-
tivity of peptide inhibition to direction of flow of permeant
ions may account for the fact that inhibition was not appar-
ent in vesicle experiments, since Ca2 flow from the lumen
to cytoplasm (trans to cis) would reduce peptide-induced
inhibition. The cis [Ca2]-dependence of inhibition would
also reduce the efficacy of inhibition in the vesicle experi-
ments since the extravesicular [Ca2] was considerably less
than 100 M during maximum rates of release. Although
inhibition dominated the effect of peptide A on RyRs in
bilayers, it might not reflect a physiological action of the
DHPR, since the II-III loop in vivo is physically constrained
by the DHPR’s location in the T-tubule membrane and may
not be free to enter the channel pore. However, inhibition
must be considered when studying the action of the II-III
loop, or loop peptides, on Ca2 release from SR or on single
RyR channels.
In conclusion, we have shown that peptides correspond-
ing to an amino acid sequence in the N-terminal region of
the II-III loop of the skeletal muscle DHPR activate ryan-
odine-sensitive Ca2 release from SR vesicles and activate
single RyR channels incorporated into lipid bilayers. Study
of RyR channel activation by the peptide is complicated by
a competing strong inhibitory action of the peptide. The
results show that activation of RyRs by the peptide is not
dependent on Ser687 in the DHPR II-III loop and that
activation of the RyR by the peptide is facilitated when
FKBP12 is bound to the RyR. These observations suggest
that activation of the RyR by the DHPR II-III loop requires
a complex sequence of signals passing from the II-III loop
binding site to the RyR channel pore. The inhibitory action
of peptide binding could provide a useful tool to probe the
RyR pore, but inhibition is unlikely to be relevant to RyR
function in vivo.
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